Oprah Winfrey 'Ozempic Feet' Rumors Hard to Ignore

Recent sightings of Oprah Winfrey at high-profile events have intensified online speculation about 'Ozempic feet,' a rumored side effect tied to her use of GLP-1 medications for weight loss. While Winfrey has openly discussed her experience with these drugs—without naming the specific brand—videos from Paris Fashion Week in March 2026 captured her appearing dramatically thinner and struggling with mobility, prompting widespread chatter on platforms like X.

What Sparked the 'Ozempic Feet' Buzz at Paris Fashion Week?

In March 2026, the daytime talk show host and OWN Network CEO attended Paris Fashion Week, where a video of her looking noticeably slimmer went viral. Observers didn't just note the weight loss; they zeroed in on her gait. "She walks like she's lost muscle along with body fat. Ozempic seems to cause premature aging," one X user commented after viewing footage of Winfrey taking slow, short steps.

The concerns didn't stop there. The same week, at Stella McCartney's fashion show in Paris—wearing a completely different ensemble—Winfrey displayed similar signs of frailty. "Oprah is also walking like she needs orthopedic surgery," another user noted. A separate clip showed her shambling toward her car, inspiring the quip, "Oprah's Ozempic induced Biden shuffle. What a f***ing mess." These observations led many to conclude she was suffering from 'Ozempic feet,' a term describing perceived weakening or structural changes in the feet linked to GLP-1 drugs like Ozempic.

Earlier Rumors from the NAACP Image Awards

The Paris incidents weren't isolated. Gossip about Winfrey's purported Ozempic feet had circulated a year prior, during her appearance at the NAACP Image Awards in February 2025. Images from the event, alongside those of Sharon Osbourne, stirred similar discussions about foot appearance and mobility.

Expert Insight: Dr. Barry Weintraub on 'Ozempic Feet'

Plastic surgeon Dr. Barry Weintraub addressed the phenomenon in an interview with the Daily Mail shortly after the NAACP event. Analyzing photos, particularly of Osbourne, he explained: "The veiny and sagging skin on the top and sides of the foot might be a result of the new lack of water retention due to a decreased BMI cause[d] by Ozempic." While his comments focused on Osbourne, they resonated with the broader conversation around Winfrey, highlighting how rapid weight loss from GLP-1 agonists can alter skin elasticity and fluid balance in extremities like the feet.

"The veiny and sagging skin the top and sides of the foot might be a result of the new lack of water retention due to a decreased BMI cause[d] by Ozempic," Dr. Barry Weintraub told the Daily Mail.

Understanding 'Ozempic Feet' in the Context of GLP-1 Medications

GLP-1 receptor agonists like Ozempic (semaglutide) are widely used for weight management and type 2 diabetes. These injectable medications mimic the GLP-1 hormone, which regulates blood sugar, slows gastric emptying, and reduces appetite, often leading to significant fat loss. Oprah has shared her positive experiences with such therapies, crediting them for her transformation.

However, rapid weight loss—sometimes 15-20% of body weight—can outpace the body's ability to adapt. This may contribute to anecdotal reports of 'Ozempic feet,' where feet appear deflated, veiny, or less supportive due to:

• Loss of subcutaneous fat: Feet naturally have fat pads that cushion and fill out the structure. Quick fat reduction can make bones and veins more prominent.
• Reduced water retention: As Dr. Weintraub noted, lower BMI from GLP-1s decreases fluid retention, exacerbating sagging skin.
• Muscle loss (sarcopenia): Weight loss isn't always fat-specific; muscle atrophy can weaken foot and leg muscles, altering gait and stability.

These changes are not unique to Ozempic but common in any swift weight reduction, whether from diet, surgery, or medications. Social media amplifies celebrity examples, turning personal observations into viral trends.

How GLP-1 Drugs Work and Why Feet Might Be Affected

Ozempic promotes weight loss by enhancing insulin secretion, suppressing glucagon, and signaling fullness to the brain. While effective, the accelerated pace can strain connective tissues. Feet, bearing constant weight, may show visible changes first—sunken arches, protruding veins, or a shuffling walk from diminished muscle support.

Practical Guidance for GLP-1 Users Concerned About 'Ozempic Feet'

If you're on Ozempic or similar GLP-1s like Wegovy, Mounjaro, or Zepbound, monitor for foot changes. Consult your doctor if you notice:

• Persistent pain, swelling, or instability.
• Visible veining or skin laxity.
• Altered walking patterns.

To mitigate risks:

• Incorporate resistance training: Build muscle with exercises like calf raises, toe walks, and squats to preserve foot strength.
• Stay hydrated and use moisturizers: Counteract skin dryness and support collagen.
• Consider supportive footwear: Orthotic inserts or cushioned shoes can help during transition.
• Track symptoms: Apps like Shotlee allow users to log side effects, medication doses, and mobility changes for better doctor discussions.

Patients should weigh benefits—improved metabolic health, reduced cardiovascular risk—against cosmetic or functional concerns. Gradual dosing uptitration minimizes rapid shifts.

Safety Profile of GLP-1 Medications Beyond Feet

Common GLP-1 side effects include nausea, gastrointestinal issues, and fatigue, but foot-specific complaints remain largely anecdotal. No large-scale studies confirm 'Ozempic feet' as a direct effect, but dermatologists and podiatrists note parallels with post-bariatric changes. Always discuss with a healthcare provider before starting or stopping therapy.

Key Takeaways: What This Means for Patients and Fans

• Rumors around Oprah Winfrey's 'Ozempic feet' stem from Paris Fashion Week 2026 videos and prior NAACP 2025 sightings, echoing Dr. Weintraub's explanation of sagging, veiny skin from rapid BMI drops.
• GLP-1 drugs like Ozempic drive effective weight loss but can lead to muscle and fat loss in extremities, affecting appearance and function.
• Proactive steps like exercise and monitoring empower users to manage changes.
• Celebrity stories highlight real patient experiences—consult professionals for personalized advice.

Conclusion: Balancing Transformation and Transition

Oprah Winfrey's journey underscores GLP-1 medications' power for metabolic health, even as rumors of 'Ozempic feet' remind us of rapid weight loss's nuances. By understanding mechanisms and adopting supportive habits, users can navigate side effects confidently. For related topics like GLP-1 heart benefits or peptide comparisons, explore our guides.